Literature DB >> 1312488

The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotrophin receptor.

E Harfst1, A P Johnstone, I Gout, A H Taylor, M D Waterfield, S S Nussey.   

Abstract

In order to produce significant quantities of the human thyrotrophin (TSH) receptor we have investigated the use of two eukaryotic high expression systems. DNA encoding the receptor was obtained by the polymerase chain reaction (PCR) applied to thyroid cDNA. Receptor DNA was inserted into the baculovirus system; despite high mRNA levels there was little or no demonstrable protein production. However, using a novel amplifiable glutamine synthetase system, clones of transfected Chinese hamster ovary (CHO) cells expressed a high affinity TSH receptor (KD 0.225 +/- 0.046 nM, Bmax 20,000-45,000 sites/cell for individual clones). This was coupled to adenylate cyclase as measured by a TSH-stimulatable increase in extracellular cyclic AMP (cAMP), a detectable response being noted at 1 microU/ml TSH with half-maximal at around 25-50 microU/ml. The high expression allowed detection of both TSH binding inhibition and adenylate cyclase stimulation by autoantibodies in unfractionated sera from patients with Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312488     DOI: 10.1016/0303-7207(92)90152-v

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

1.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

Authors:  G Carayanniotis; G C Huang; L B Nicholson; T Scott; P Allain; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

2.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

3.  AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization.

Authors:  Chris P Hughes; Neil M J O'Flynn; Maureen Gatherer; Michelle E McClements; Jennifer A Scott; Robert E MacLaren; Srinivas Goverdhan; Martin J Glennie; Andrew J Lotery
Journal:  Mol Ther Methods Clin Dev       Date:  2018-11-22       Impact factor: 6.698

Review 4.  In a Class of Their Own - RXFP1 and RXFP2 are Unique Members of the LGR Family.

Authors:  Emma J Petrie; Samantha Lagaida; Ashish Sethi; Ross A D Bathgate; Paul R Gooley
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-07       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.